Literature DB >> 18378158

Immune transcriptome alterations in the temporal cortex of subjects with autism.

Krassimira Garbett1, Philip J Ebert1, Amanda Mitchell1, Carla Lintas2, Barbara Manzi3, Károly Mirnics4, Antonio M Persico5.   

Abstract

Autism is a severe disorder that involves both genetic and environmental factors. Expression profiling of the superior temporal gyrus of six autistic subjects and matched controls revealed increased transcript levels of many immune system-related genes. We also noticed changes in transcripts related to cell communication, differentiation, cell cycle regulation and chaperone systems. Critical expression changes were confirmed by qPCR (BCL6, CHI3L1, CYR61, IFI16, IFITM3, MAP2K3, PTDSR, RFX4, SPP1, RELN, NOTCH2, RIT1, SFN, GADD45B, HSPA6, HSPB8 and SERPINH1). Overall, these expression patterns appear to be more associated with the late recovery phase of autoimmune brain disorders, than with the innate immune response characteristic of neurodegenerative diseases. Moreover, a variance-based analysis revealed much greater transcript variability in brains from autistic subjects compared to the control group, suggesting that these genes may represent autism susceptibility genes and should be assessed in follow-up genetic studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18378158      PMCID: PMC2693090          DOI: 10.1016/j.nbd.2008.01.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  38 in total

1.  Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia.

Authors:  S Hossein Fatemi; Julie Earle; Reena Kanodia; David Kist; Effat S Emamian; Paul H Patterson; Limin Shi; Robert Sidwell
Journal:  Cell Mol Neurobiol       Date:  2002-02       Impact factor: 5.046

2.  Superior temporal gyrus, language function, and autism.

Authors:  Erin D Bigler; Sherstin Mortensen; E Shannon Neeley; Sally Ozonoff; Lori Krasny; Michael Johnson; Jeffrey Lu; Sherri L Provencal; William McMahon; Janet E Lainhart
Journal:  Dev Neuropsychol       Date:  2007       Impact factor: 2.253

Review 3.  Diagnosis of autism.

Authors:  Gillian Baird; Hilary Cass; Vicky Slonims
Journal:  BMJ       Date:  2003-08-30

4.  Dysregulation of Reelin and Bcl-2 proteins in autistic cerebellum.

Authors:  S H Fatemi; J M Stary; A R Halt; G R Realmuto
Journal:  J Autism Dev Disord       Date:  2001-12

5.  Glutamic acid decarboxylase 65 and 67 kDa proteins are reduced in autistic parietal and cerebellar cortices.

Authors:  S Hossein Fatemi; Amy R Halt; Joel M Stary; Reena Kanodia; S Charles Schulz; George R Realmuto
Journal:  Biol Psychiatry       Date:  2002-10-15       Impact factor: 13.382

Review 6.  Immunity, neuroglia and neuroinflammation in autism.

Authors:  Carlos A Pardo; Diana L Vargas; Andrew W Zimmerman
Journal:  Int Rev Psychiatry       Date:  2005-12

7.  Correlation of transcriptome profile with electrical activity in temporal lobe epilepsy.

Authors:  Dominique Arion; Michael Sabatini; Travis Unger; Jesús Pastor; Lidia Alonso-Nanclares; Inmaculada Ballesteros-Yáñez; Rafael García Sola; Alberto Muñoz; Károly Mirnics; Javier DeFelipe
Journal:  Neurobiol Dis       Date:  2006-02-09       Impact factor: 5.996

8.  Two new behavioral QTLs, Emo4 and Reb1, map to mouse Chromosome 1: Congenic strains and candidate gene identification studies.

Authors:  Ana Maria Rodriguez de Ledesma; Aarti N Desai; Valerie J Bolivar; Derek J Symula; Lorraine Flaherty
Journal:  Mamm Genome       Date:  2006-02-07       Impact factor: 2.957

9.  Disruption of cerebral cortex MET signaling in autism spectrum disorder.

Authors:  Daniel B Campbell; Rosanna D'Oronzio; Krassi Garbett; Philip J Ebert; Karoly Mirnics; Pat Levitt; Antonio M Persico
Journal:  Ann Neurol       Date:  2007-09       Impact factor: 10.422

10.  A genetic variant that disrupts MET transcription is associated with autism.

Authors:  Daniel B Campbell; James S Sutcliffe; Philip J Ebert; Roberto Militerni; Carmela Bravaccio; Simona Trillo; Maurizio Elia; Cindy Schneider; Raun Melmed; Roberto Sacco; Antonio M Persico; Pat Levitt
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-19       Impact factor: 11.205

View more
  163 in total

1.  Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.

Authors:  Michael Feyder; Rose-Marie Karlsson; Poonam Mathur; Matthew Lyman; Roland Bock; Reza Momenan; Jeeva Munasinghe; Maria Luisa Scattoni; Jessica Ihne; Marguerite Camp; Carolyn Graybeal; Douglas Strathdee; Alison Begg; Veronica A Alvarez; Peter Kirsch; Marcella Rietschel; Sven Cichon; Henrik Walter; Andreas Meyer-Lindenberg; Seth G N Grant; Andrew Holmes
Journal:  Am J Psychiatry       Date:  2010-10-15       Impact factor: 18.112

Review 2.  Genes, circuits, and precision therapies for autism and related neurodevelopmental disorders.

Authors:  Mustafa Sahin; Mriganka Sur
Journal:  Science       Date:  2015-10-15       Impact factor: 47.728

3.  Expression Analysis of BDNF, BACE1, and Their Natural Occurring Antisenses in Autistic Patients.

Authors:  Soudeh Ghafouri-Fard; Amir Namvar; Shahram Arsang-Jang; Alireza Komaki; Mohammad Taheri
Journal:  J Mol Neurosci       Date:  2019-11-23       Impact factor: 3.444

4.  Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits.

Authors:  Guomei Tang; Kathryn Gudsnuk; Sheng-Han Kuo; Marisa L Cotrina; Gorazd Rosoklija; Alexander Sosunov; Mark S Sonders; Ellen Kanter; Candace Castagna; Ai Yamamoto; Zhenyu Yue; Ottavio Arancio; Bradley S Peterson; Frances Champagne; Andrew J Dwork; James Goldman; David Sulzer
Journal:  Neuron       Date:  2014-08-21       Impact factor: 17.173

5.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2010-11-20       Impact factor: 3.478

Review 6.  Using genetic findings in autism for the development of new pharmaceutical compounds.

Authors:  Jacob A S Vorstman; Will Spooren; Antonio M Persico; David A Collier; Stefan Aigner; Ravi Jagasia; Jeffrey C Glennon; Jan K Buitelaar
Journal:  Psychopharmacology (Berl)       Date:  2013-11-30       Impact factor: 4.530

Review 7.  Emerging roles of TET proteins and 5-hydroxymethylcytosines in active DNA demethylation and beyond.

Authors:  Junjie U Guo; Yijing Su; Chun Zhong; Guo-li Ming; Hongjun Song
Journal:  Cell Cycle       Date:  2011-08-15       Impact factor: 4.534

8.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

9.  Resveratrol Ameliorates Dysregulation of Th1, Th2, Th17, and T Regulatory Cell-Related Transcription Factor Signaling in a BTBR T + tf/J Mouse Model of Autism.

Authors:  Saleh A Bakheet; Mohammad Zeed Alzahrani; Mushtaq Ahmad Ansari; Ahmed Nadeem; Khairy M A Zoheir; Sabry M Attia; Laila Yousef Al-Ayadhi; Sheikh Fayaz Ahmad
Journal:  Mol Neurobiol       Date:  2016-08-30       Impact factor: 5.590

10.  Myeloid dendritic cells frequencies are increased in children with autism spectrum disorder and associated with amygdala volume and repetitive behaviors.

Authors:  Elizabeth Breece; Brian Paciotti; Christine Wu Nordahl; Sally Ozonoff; Judy A Van de Water; Sally J Rogers; David Amaral; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2012-10-11       Impact factor: 7.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.